Source: Current Computer-Aided Drug Design. Unidades: FCFRP, FFCLRP
Subjects: DOENÇA DE ALZHEIMER, MODELAGEM MOLECULAR, PLANEJAMENTO DE FÁRMACOS, INIBIDORES DE ENZIMAS, FARMACOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CASTRO, Leandro L. et al. Proposition of potential GSK-3β inhibitors for the treatment of Alzheimer’s disease: a molecular modeling study. Current Computer-Aided Drug Design, v. 16, n. 5, p. 541-554, 2020Tradução . . Disponível em: https://doi.org/10.2174/1573409915666191015110734. Acesso em: 27 set. 2024.APA
Castro, L. L., Picanço, L. C. S., Silva, J. V., Souza, L. R., Sousa, K. P. A., Pinheiro, A. A., et al. (2020). Proposition of potential GSK-3β inhibitors for the treatment of Alzheimer’s disease: a molecular modeling study. Current Computer-Aided Drug Design, 16( 5), 541-554. doi:10.2174/1573409915666191015110734NLM
Castro LL, Picanço LCS, Silva JV, Souza LR, Sousa KPA, Pinheiro AA, Chaves GA, Teixeira HRC, Silva GM da, Taft CA, Silva CHT de P da, Melim LI da SH. Proposition of potential GSK-3β inhibitors for the treatment of Alzheimer’s disease: a molecular modeling study [Internet]. Current Computer-Aided Drug Design. 2020 ; 16( 5): 541-554.[citado 2024 set. 27 ] Available from: https://doi.org/10.2174/1573409915666191015110734Vancouver
Castro LL, Picanço LCS, Silva JV, Souza LR, Sousa KPA, Pinheiro AA, Chaves GA, Teixeira HRC, Silva GM da, Taft CA, Silva CHT de P da, Melim LI da SH. Proposition of potential GSK-3β inhibitors for the treatment of Alzheimer’s disease: a molecular modeling study [Internet]. Current Computer-Aided Drug Design. 2020 ; 16( 5): 541-554.[citado 2024 set. 27 ] Available from: https://doi.org/10.2174/1573409915666191015110734